Cell-based Assay Market 2024-29 | Exploring Industry Demand, Growth, Future Projection and Major Key Compaies | Danaher Corporation, Thermo Fisher Scientific, and Merck KGaA

Comprehensive Insights: Global Cell-based Assay Market Report, 2024-29

MarkNtel Advisors, a prominent market research firm, has recently published a report titled "Global Cell-based Assay Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2029." This comprehensive study explores into the industry, offering an in-depth examination of the Cell-based Assay market, encompassing research findings, size, market share, trends, and growth projections.

Furthermore, the report encompasses competitor and regional analyses, spotlighting the most recent developments in the market.

Report Historical Data:

  > Historical Data: 2019-22

  > Base Year: 2023

  > Forecast Period: 2024-29

Get Report Free Sample Copy, NOW! - https://www.marknteladvisors.com/query/request-sample/cell-based-assay-market.html

Global Cell-based Assay Market Overview:

The Global Cell-based Assay Market is anticipated to grow at a CAGR of around 8.4% during the forecast period, i.e., 2024-29. The global market size is expected to exceed USD 29 billion by 2029. The factors attributing to the growth in the demand for cell-based assays across the globe are; the rising drug discovery activities by pharmaceutical companies, the surging inclination of consumers towards personalized medicines, and rising government funding and private investments in life sciences and healthcare research.

What are the top listed Cell-based Assay Companies in the Global market?

* Cell Signaling Technology, Inc.

 * Danaher Corporation

 * Thermo Fisher Scientific

 * Business Description

 * Merck KGaA

 * Lonza Group

 * Abcam plc.

 * Becton, Dickenson and Company

 * Promega Corporation

 * Bio-Rad Laboratories, Inc.

 * PerkinElmer Inc.

 * Cayman Chemical

 * R&D Systems, Inc.

 * AnaSpec

 * Enzo Life Sciences, Inc.

 * Menarini Silicon Biosystems, Inc.

 * Others

What Factor Driving the Cell-based Assay Industry Growth in the coming years?

Increasing Demand for Targeted Therapies to Boost the Demand for Cell-based Assay - With progressions in scientific knowledge about diseases, there is a mounting focus on emerging targeted therapies that accurately address specific molecular pathways linked to ailments. The targeted therapies offer precision and effective treatment for diseases such as cancer, auto-immune diseases, etc. Therefore, bio-pharmaceutical companies such as Thermo Fisher Scientific, PerkinElmer, etc., are increasingly developing these targeted therapies to offer accurate treatment to patients suffering from deadly diseases. [read more - https://www.marknteladvisors.com/research-library/cell-based-assay-market.html ]

What segmentation included in Global Cell-based Assay market?

By Products & Services

 * Consumables

  ** Reagents

  ** Assay Kits

   *** Reporter Gene Assays

   *** Cell Growth Assays

   *** Second Messenger Assays          

   *** Cell Death Assays

   *** Other (Ion Channel Assays, Cell Adhesion Assays, etc.)

  ** Microplates

  ** Cell Lines

   *** Immortalized Cell Lines

   *** Primary Cell Lines

   *** Stem Cell Lines

  ** Probes & Labels

  ** Others (Microplates, Pipette Tips, etc.)

 * Instruments & Software

 * Services

By Application

 * Drug Discovery

 * Absorption, Distribution, Metabolism and Excretion (ADME) Studies

 * Others (Basic Research, Predictive Toxicology Studies, etc.)

By Technology

 * Automated Handling

 * Flow Cytometry

 * Others (Label-free Detection, High-throughput Screening, etc.)

By End User

 * Pharmaceutical & Biotechnological Companies

 * Academic & Government Institutes

 * Contract Research Organizations

 * Others (Research institutes, Contract Development and Manufacturing Organizations (CDMOs), etc.)

Separation By Region

 * North America

 * South America

 * Europe

 * The Middle East and Africa

 * Asia-Pacific

Note - If you require any specific details that are currently absent from the report, we would be delighted to furnish them through our customization services. [Visit - https://www.marknteladvisors.com/query/request-customization/cell-based-assay-market.html ]

Reason to Buy This Report:

 > In-depth analysis covering Cell-based Assay Market Size, Share, Growth, Trends, and Future Outlook.

 > Focus on Industry Dynamics, Demand, and Development Opportunities.

 > Incorporates Latest Investment and Industry Reports for a comprehensive view.

 > Accurate Forecast data to guide informed decision-making.

 > Presented in English for clear and concise understanding.

Recent Press Release:

 >> https://www.innovations-i.com/release/1158359.html

 >> https://www.innovations-i.com/release/1158358.html

 >> https://www.innovations-i.com/release/1158357.html

 >> https://www.innovations-i.com/release/1158356.html

 >> https://www.innovations-i.com/release/1158355.html

 >> https://www.innovations-i.com/release/1158354.html

 >> https://www.innovations-i.com/release/1158353.html

 >> https://www.innovations-i.com/release/1158352.html

 >> https://www.innovations-i.com/release/1158351.html

Call 📞 +1 628 895 8081 +91 120 4278433

Email: 📧 sales@marknteladvisors.com

Corporate Office: 🏢 Office No.106, H-160, Sector 63, Noida, Uttar Pradesh - 201301, India

About Us -

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

This release was published on openPR.